181 related articles for article (PubMed ID: 12534859)
1. Donepezil for nursing home patients with dementia: a reinterpretation of the evidence.
Steinman MA; Covinsky KE
J Am Geriatr Soc; 2003 Jan; 51(1):132; author reply 132-3. PubMed ID: 12534859
[No Abstract] [Full Text] [Related]
2. Getting donepezil into the nursing home.
Finucane TE
J Am Geriatr Soc; 2003 Jan; 51(1):133-4; author reply 134. PubMed ID: 12534861
[No Abstract] [Full Text] [Related]
3. Donepezil use in the treatment of dementia associated with Down syndrome.
Cipriani G; Bianchetti A; Trabucchi M
Arch Neurol; 2003 Feb; 60(2):292; author reply 292. PubMed ID: 12580720
[No Abstract] [Full Text] [Related]
4. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
[TBL] [Abstract][Full Text] [Related]
5. Cholinesterase inhibitors for treatment of dementia associated with Parkinson's disease.
Cummings JL
J Neurol Neurosurg Psychiatry; 2005 Jul; 76(7):903-4. PubMed ID: 15965192
[No Abstract] [Full Text] [Related]
6. Long term safety and efficacy of donepezil in the treatment of dementia in Alzheimer's disease in adults with Down syndrome: open label study.
Prasher VP; Adams C; Holder R;
Int J Geriatr Psychiatry; 2003 Jun; 18(6):549-51. PubMed ID: 12789681
[No Abstract] [Full Text] [Related]
7. Feasibility of vascular dementia treatment with cholinesterase inhibitors.
Li Y; Meyer JS; Haque MA; Chowdhury MH; Hinh P; Quach M
Int J Geriatr Psychiatry; 2002 Feb; 17(2):194-6. PubMed ID: 11813286
[No Abstract] [Full Text] [Related]
8. Cardiovascular effects of donepezil in patients with dementia.
McLaren AT; Allen J; Murray A; Ballard CG; Kenny RA
Dement Geriatr Cogn Disord; 2003; 15(4):183-8. PubMed ID: 12626850
[TBL] [Abstract][Full Text] [Related]
9. Kinematic analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer dementia.
Hegerl U; Mergl R; Henkel V; Gallinat J; Kotter G; Müller-Siecheneder F; Pogarell O; Juckel G; Schröter A; Bahra R; Emir B; Laux G; Möller HJ
J Clin Psychopharmacol; 2003 Apr; 23(2):214-6. PubMed ID: 12640228
[No Abstract] [Full Text] [Related]
10. Pisa syndrome due to a cholinesterase inhibitor (donepezil): a case report.
Miyaoka T; Seno H; Yamamori C; Inagaki T; Itoga M; Tsubouchi K; Horiguchi J
J Clin Psychiatry; 2001 Jul; 62(7):573-4. PubMed ID: 11488374
[No Abstract] [Full Text] [Related]
11. The long-term efficacy and tolerability of donepezil in patients with vascular dementia.
Wilkinson D; Róman G; Salloway S; Hecker J; Boundy K; Kumar D; Posner H; Schindler R
Int J Geriatr Psychiatry; 2010 Mar; 25(3):305-13. PubMed ID: 19623601
[TBL] [Abstract][Full Text] [Related]
12. Can donepezil be considered a mild antipsychotic in dementia treatment? A report of donepezil use in 6 patients.
Terao T; Shimomura T; Nakamura J
J Clin Psychiatry; 2003 Nov; 64(11):1392-3. PubMed ID: 14658957
[No Abstract] [Full Text] [Related]
13. Donepezil for Huntington's disease.
Fernandez HH; Friedman JH; Grace J; Beason-Hazen S
Mov Disord; 2000 Jan; 15(1):173-6. PubMed ID: 10634264
[No Abstract] [Full Text] [Related]
14. [Severe bradycardia in general anaesthesia in a patient treated with cholinesterase inhibitors for dementia].
Jellinge ME; Ferguson AH
Ugeskr Laeger; 2015 Feb; 177(7):. PubMed ID: 25697071
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effect of donepezil augmentation for the management of comorbid schizophrenia and dementia.
Stryjer R; Strous RD; Bar F; Werber E; Shaked G; Buhiri Y; Kotler M; Weizman A; Rabey JM
Clin Neuropharmacol; 2003; 26(1):12-7. PubMed ID: 12567159
[TBL] [Abstract][Full Text] [Related]
16. Behavioral complications associated with donepezil.
Wengel SP; Roccaforte WH; Burke WJ; Bayer BL; McNeilly DP; Knop D
Am J Psychiatry; 1998 Nov; 155(11):1632-3. PubMed ID: 9812142
[No Abstract] [Full Text] [Related]
17. Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study.
Ravina B; Putt M; Siderowf A; Farrar JT; Gillespie M; Crawley A; Fernandez HH; Trieschmann MM; Reichwein S; Simuni T
J Neurol Neurosurg Psychiatry; 2005 Jul; 76(7):934-9. PubMed ID: 15965198
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the efficacy of donepezil in Parkinson's disease with dementia and dementia with Lewy bodies.
Thomas AJ; Burn DJ; Rowan EN; Littlewood E; Newby J; Cousins D; Pakrasi S; Richardson J; Sanders J; McKeith IG
Int J Geriatr Psychiatry; 2005 Oct; 20(10):938-44. PubMed ID: 16163744
[TBL] [Abstract][Full Text] [Related]
19. Questions about donepezil.
Elie LM; Cole MG
CMAJ; 1998 Apr; 158(8):1014-5. PubMed ID: 9580729
[No Abstract] [Full Text] [Related]
20. [A reply to Pfizer: Still no reason to change SBU's conclusions on drugs against dementia].
Edhag O; Norlund A
Lakartidningen; 2007 Jan 10-16; 104(1-2):55. PubMed ID: 17323745
[No Abstract] [Full Text] [Related]
[Next] [New Search]
